Analyst Ratings for Dianthus Therapeutics (DNTH)
DNTH Rating Summary
DNTH Price Target Summary
- Highest: $200.00 (Guggenheim)
- Lowest: $44.00 (Wedbush)
- Average: $126.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$126.92 (+18.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$126.92 (+18.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/8/2026 | Wolfe Research » Updated 6/10/2026 |
Andy Chen | New Coverage | Outperform (N/A) |
98.00 (N/A) |
86.20 (106.74) |
23.83% | Details |
| 3/10/2026 | Raymond James » Updated 8/5/2026 |
Ryan Deschner | Upgrade | Strong Buy (Outperform) |
131.00 (125.00) |
65.20 (106.74) |
63.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
